| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263
Address all correspondence and requests for reprints to: Dr. Margot Ip, Grace Cancer Drug Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263. E-mail: margot.ip{at}roswellpark.org
Tumor necrosis factor-
(TNF) is a physiologically significant
regulator of mammary gland development, stimulating growth and
branching morphogenesis of mammary epithelial cells (MEC) and
modulating functional differentiation. The present studies were
performed to determine the mechanism by which TNF modulated functional
differentiation. In rat MEC in primary culture, TNF inhibited
accumulation of whey acidic protein and ß-casein messenger RNAs in a
time- and concentration-dependent manner. In contrast, levels of
transferrin messenger RNA, the product of another milk protein gene,
were not inhibited by TNF, suggesting selectivity. Using a nuclear
run-on assay in the immortalized HC11 mammary epithelial cell line and
the transcriptional inhibitor actinomycin D in MEC in primary culture,
the effects of TNF were shown to be mediated by both a decrease in
transcription and a decrease in the stability of the whey acidic
protein and ß-casein transcripts. Additionally, TNF stimulated the
binding of nuclear factor-
B to a consensus
B-oligonucleotide,
increased the stability of matrix metalloproteinase-9 (MMP-9)
transcripts, and increased MMP-9 activity. Together, these data suggest
that TNF may exert its effects on milk protein gene expression either
directly via nuclear factor-
B modulation of transcription, or
indirectly via MMP-9-induced remodeling of the architectural or
hormonal environment surrounding the MEC.
This article has been cited by other articles:
![]() |
M. A. Warren, S. F. Shoemaker, D. J. Shealy, W. Bshar, and M. M. Ip Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice Mol. Cancer Ther., September 1, 2009; 8(9): 2655 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, M. A. Warren, S. F. Shoemaker, and M. M. Ip NF{kappa}B1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NF{kappa}B2/p52 and RelB Endocrinology, January 1, 2007; 148(1): 268 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, H. Zhang, L. Lee, and M. M. Ip The Liver-Enriched Inhibitory Protein Isoform of CCAAT/Enhancer-Binding Protein {beta}, But Not Nuclear Factor-{kappa}B, Mediates the Transcriptional Inhibition of {beta}-Casein by Tumor Necrosis Factor-{alpha} Endocrinology, June 1, 2004; 145(6): 2833 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Komine, T. Kuroishi, Y. Komine, K. Watanabe, J. Kobayashi, T. Yamaguchi, S.-i. Kamata, and K. Kumagai Induction of Nitric Oxide Production Mediated by Tumor Necrosis Factor Alpha on Staphylococcal Enterotoxin C-Stimulated Bovine Mammary Gland Cells Clin. Vaccine Immunol., January 1, 2004; 11(1): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |